| Intervention | No. of studies II | Event rate in control group (%) | Large trials (n, %) | Effect size of odds ratio (95% CI) | Heterogeneity (I2) |
---|---|---|---|---|---|---|
Abroug F 2011 [9] | Prone ventilation | 7 | 37.3 | 3 (42.9) | 0.91 (0.75, 1.1) | 0% |
Afshari A 2007 [10] | Antithrombin III | 20 | 39.9 | 1 (5) | 0.96 (0.89, 1.03) | 0% |
Afshari A 2011 [11] | Inhaled nitric oxide for ARDS | 14 | 38.6 | 3 (21.4) | 1.06 (0.93, 1.22) | 0% |
Annane D 2009 [12] | Corticosteroids | 20 | 36.4 | 4 (20) | 0.87 (0.74, 1.01) | 44% |
Augustes R 2011 [13] | Sedation interruption | 5 | 37.2 | 1 (20) | 0.84 (0.58, 1.21) | 19.4% |
Barkun AN 2012 [14] | PPI for stress-related mucosal bleeding | 8 | 18.7 | 3 (37.5) | 1.19 (0.84, 1.68) | 0% |
Blackwood B 2011 [15] | Weaning protocol | 10 | 14.7 | 5 (50) | 0.98 (0.48, 2.02) | 57% |
Burns KE 2011 [16] | Volume-limited ventilation | 10 | 42.5 | 2 (20) | 0.84 (0.7, 1.0) | 43.1% |
Delaney AP 2011 [17] | Albumin for resuscitation | 17 | 33.8 | 1 (5.9) | 0.82 (0.67, 1.0) | 0% |
Kopterides P 2010 [18] | Procalcitonin-guided | 6 | 22.6 | 1 (16.7) | 0.93 (0.69, 1.26) | 0% |
Landoni G 2010 [19] | Levosimendan | 27 | 22.4 | 3 (11.1) | 0.74 (0.62, 0.89) | 11.3% |
Laupland KB 2007 [20] | Polyclonal intravenous immunoglobulin | 14 | 41.8 | 2 (14.3) | 0.66 (0.53, 0.83) | 53.8% |
Marik PE 2008 [21] | Immunonutrition | 24 | 25.8 | 5 (20.8) | 0.85 (0.64, 1.13) | 44% |
Phoenix SI 2009 [22] | High PEEP | 6 | 38.5 | 3 (50) | 0.87 (0.78, 0.96) | 0% |
Pileggi C 2011 [23] | Selective decontamination of the digestive or respiratory tract | 11 | NR | 6 (54.5) | 1.1 (0.98, 1.24) | 0% |
Puskarich MA 2009 [24] | Glucose-insulin-potassium infusion | 23 | 9 | 5 (21.7) | 1.02 (0.93, 1.11) | 0% |
Serpa Neto A 2012 [25] | Vasopressin/terlipressin | 9 | 50.3 | 1 (11.1) | 0.87 (0.79, 0.96) | 0% |
Shah MR 2005 [26] | Pulmonary artery catheter | 13 | 32.7 | 4 (30.8) | 1.04 (0.9, 1.2) | 0% |
Shan L 2011 [27] | Intensive insulin therapy | 5 | 34.7 | 2 (40) | 0.98 (0.82, 1.16) | 0% |
Siempos II 2010 [28] | Probiotics | 4 | 19.5 | 1 (25) | 0.75 (0.47, 1.21) | 0% |
Tan JA 2010 [29] | Dexmedetomidine | 16 | 8.7 | 3 (18.8) | 0.85 (0.64, 1.17) | 0% |
Vasu TS 2012 [30] | Dopamine/norepinephrine | 6 | 54.0 | 2 (33.3) | 0.43 (0.26, 0.69) | 65.4% |
Visser J 2011 [31] | Micronutrient supplementation | 10 | 28.8 | 1 (10) | 0.78 (0.67, 0.90) | 0% |
Wang F 2011 [32] | Timing of tracheotomy | 7 | 33.0 | 2 (28.6) | 0.86 (0.65, 1.13) | 45% |
Wang F 2012 [33] | Subglottic secretion drainage | 9 | 22.1 | 3 (33.3) | 0.97 (0.84, 1.12) | 0% |
Zarychanski R 2009 [34] | Hydroxyethyl starch resuscitation | 10 | 31.1 | 1 (10) | 1.07 (0.85, 1.34) | 0% |
Zhongheng Z 2010 [35] | Dose of CRRT | 6 | 45.4 | 5 (83.3) | 0.91 (0.77, 1.08) | 75% |